XTL Biopharma (XTLB) Posts Breakeven Q4 Loss

XTL Biopharma (NASDAQ: XTLB) reported Q4 EPS of $-0.00, versus $-0.00 reported last year.

For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Bernstein SocGen Group Upgrades J.B. Hunt Transport Services (JBHT) to Outperform